Dennis Holl

Dennis Holl, PhD, CFA, serves as the Senior Director of BioPharma Business Development at Guardant Health. Previously, Dennis held various leadership roles at Exact Sciences, including Product Lifecycle Director for Tumor Sequencing and Head of Precision Oncology Market Insights. At Amgen, Dennis contributed as Director of Corporate Strategy and Director of Genetics Strategy. Experience also includes a position as Global Market Planning Manager at Genentech and as a Management Consultant at The Boston Consulting Group. Dennis earned a Ph.D. in Genetics from Harvard University and holds a Bachelor of Science in Biology from the Massachusetts Institute of Technology.